✦ LIBER ✦

BDM (2,3-butanedione monoxime), an inhibitor of myosin-actin interaction, suppresses myofibrillogenesis in skeletal muscle cells in culture

✍ Scribed by Y. Soeno; Y. Shimada; T. Obinata

Book ID: 106140502
Publisher: Springer-Verlag
Year: 1999
Tongue: English
Weight: 734 KB
Volume: 295
Category: Article
ISSN: 0302-766X
DOI: 10.1007/s004410051237

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The influence of 2,3-butanedione 2-monox

The influence of 2,3-butanedione 2-monoxime (BDM) on the interaction between actin and myosin in solution and in skinned muscle fibres

✍ D. F. A. Mckillop; N. S. Fortune; K. W. Ranatunga; M. A. Geeves 📂 Article 📅 1994 🏛 Springer Netherlands 🌐 English ⚖ 850 KB

2,3-butanedione 2-monoxime (BDM) inhibits muscle contraction and actomyosin ATPase both in fibres and in solution. It is potentially useful as a tool for exploring weak interactions between actin and myosin. We have examined the effect of BDM on several key steps of the myosin subfragment-1 and acto

EFFECTS OF THE MYOSIN INHIBITOR 2,3-BUTA

EFFECTS OF THE MYOSIN INHIBITOR 2,3-BUTANEDIONE MONOXIME (BDM) ON CELL SHAPE, LOCOMOTION AND FLUID PINOCYTOSIS IN HUMAN POLYMORPHONUCLEAR LEUCOCYTES

✍ N. Urwyler; P. Eggli; H.U. Keller 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 696 KB

## Abstract We investigated the role of myosin in polymorphonuclear leucocyte (PMN) shape changes, locomotion, and fluid pinocytosis using the myosin inhibitor 2,3 butanedione monoxime (BDM). Treatment of resting spherical PMNs with BDM produced spheroid cells showing small continuous shape changes